recommended dual ocular discharge; sterile sites Ceftriaxone MIC >/= treatment regimen for specimens (blood, synovial fluid) 0.25 gonorrhoea (250mg Azithromycin MIC >/= ceftriaxone IM + 1g 0.5 azithromycin stat PO) PLUS AND no likelihood of resistance to at least reinfection THREE **Class II antibiotics Penicillin MIC >/=2 Ciprofloxacin MIC >/= 0.12 Gentamicin MIC >/=8 Spectinomycin MIC >/=64 Tetracycline MIC >/=2 *Class I antibiotics: those currently recommended for gonorrhoea treatment (dual therapy used) **Class II antibiotics:used less frequently or proposed as salvage therapy NB: all MICs in µg/ml
Ceftriaxone MIC >/= 0.25 Azithromycin MIC >/= 0.5 PLUS resistance to at least THREE **Class II antibiotics Penicillin MIC >/=2 Ciprofloxacin MIC >/= 0.12 Gentamicin MIC >/=8 Spectinomycin MIC >/=64 Tetracycline MIC >/=2 *Class I antibiotics: those currently recommended for gonorrhoea treatment (dual therapy used) **Class II antibiotics:used less frequently or proposed as salvage therapy NB: all MICs in µg/ml recommended dual treatment regimen for gonorrhoea (250mg ceftriaxone IM + 1g azithromycin stat PO) AND no likelihood of reinfection ocular discharge; sterile sites specimens (blood, synovial fluid)
Appendix_C_NMC_case_definitions.docx